Jose M Mendez-Arriaga

Dr. Jose M Mendez-Arriaga

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
NSNoelia Santamaría‐Díaz
Noelia Santamaría‐Díaz
Jose M Mendez-ArriagaJose M Mendez-Arriaga
Jose M Mendez-Arriaga
JSJuan M. Salas
Juan M. Salas
MGMiguel A. Galindo
Miguel A. Galindo

25 January 2022 in Polyhedron
Verified
Journal Article
Closed access
AHAbul Monsur Showkot Hossain
Abul Monsur Showkot Hossain
Jose M Mendez-ArriagaJose M Mendez-Arriaga
Jose M Mendez-Arriaga
CXChangkun Xia
Changkun Xia
JXJimin Xie
Jimin Xie
Santiago Gomez-RuizSantiago Gomez-Ruiz
Santiago Gomez-Ruiz

14 October 2022 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Open access
DDDiana Díaz-García
Diana Díaz-García
ÁFÁgueda Ferrer-Donato
Águeda Ferrer-Donato
Jose M Mendez-ArriagaJose M Mendez-Arriaga
Jose M Mendez-Arriaga
MCMarta Cabrera-Pinto
Marta Cabrera-Pinto
Miguel Díaz SánchezMiguel Díaz Sánchez
Miguel Díaz Sánchez
Santiago Gomez-RuizSantiago Gomez-Ruiz
Santiago Gomez-Ruiz
Amyotrophic lateral sclerosis (ALS) is a devasting neurodegenerative disease with no cure to date. Therapeutic agents used to treat ALS are very limited, although combined therapies may offer a more effective treatment strategy. Herein, we have studied the potential of nanomedicine to prepare a single platform based on mesoporous silica nanoparticles (MSNs) for the treatment of an ALS animal model with a cocktail of agents such as leptin (neuroprotective) and pioglitazone (anti-inflammatory), which have already demonstrated promising therapeutic ability in other neurodegenerative diseases. Our goal is to study the potential of functionalized mesoporous materials as therapeutic agents against ALS using MSNs as nanocarriers for the proposed drug cocktail leptin/pioglitazone (MSN-LEP-PIO). The nanostructured materials have been characterized by different techniques, which confirmed the incorporation of both agents in the nanosystem. Subsequently, the effect, in vivo, of the proposed drug cocktail, MSN-LEP-PIO, was used in the murine model of TDP-43 proteinopathy (TDP-43A315T mice). Body weight loss was studied, and using the rotarod test, motor performance was assessed, observing a continuous reduction in body weight and motor coordination in TDP-43A315T mice and wild-type (WT) mice. Nevertheless, the disease progression was slower and showed significant improvements in motor performance, indicating that TDP-43A315T mice treated with MSN-LEP-PIO seem to have less energy demand in the late stage of the symptoms of ALS. Collectively, these results seem to indicate the efficiency of the systems in vivo and the usefulness of their use in neurodegenerative models, including ALS.


1 November 2017 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
MFMarzena Fandzloch
Marzena Fandzloch
Jose M Mendez-ArriagaJose M Mendez-Arriaga
Jose M Mendez-Arriaga
MSManuel Sánchez-Moreno
Manuel Sánchez-Moreno
AWAndrzej Wojtczak
Andrzej Wojtczak
JJJulia Jezierska
Julia Jezierska
IŁIwona Łakomska
Iwona Łakomska

14 September 2017 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
JSJuan M. Salas
Juan M. Salas
ANA B. CABALLEROANA B. CABALLERO
ANA B. CABALLERO
GEGinés M. Esteban-Parra
Ginés M. Esteban-Parra
Jose M Mendez-ArriagaJose M Mendez-Arriaga
Jose M Mendez-Arriaga
Since their first synthesis back in the early 20th century, 1,2,4-triazolo[1,5- a]pyrimidines have aroused increasing interest in very diverse areas ranging from chemotherapy to agriculture or even photography. Their similarity to purines confers a potential bioactivity and this feature has been wisely exploited for therapeutic use, including antifungal, antipyretic, analgesic, antiinflammatory, antitumoral and antiparasitic properties. In this review, we focus on the compounds that these nitrogen heterocycles form with metal ions and their antiparasitic activity and therapeutic potential against two neglected diseases of tropical prevalence, leishmaniasis and Chagas disease.